Endocannabinoid
Resource Centre
TOP ARTICLES
Is Cannabidiol the Next Clinical Antioxidant?
Emerging research shows that cannabidiol holds unique properties as an antioxidant. In the scientific summary, we profile two studies that review the potential of non-psychotropic cannabidiol as an antioxidant. This research has future clinical implications for cerebral ischemia, rheumatoid arthritis, types I and II diabetes, atherosclerosis, Alzheimer’s disease, hypertension, the
Effectiveness of Prescription CBD for Epilepsy May Wane in a Quarter of Patients
Approximately 25 percent of drug-resistant epilepsy patients taking cannabidiol (CBD) developed a tolerance to the treatment, researchers said at the American Epilepsy Society annual meeting taking place Nov.30 – Dec. 4, 2018. The findings suggest that that the effectiveness of the CBD drug might wane in the long term for
Derrick DeSilva, MD, on CBD for Common Conditions, Choosing a Safe, Reliable Brand
In this video, Dr. DeSilva shares some case studies and how he is prescribing CBD for common conditions for his patients. In this video series he discusses the following: Case studies of patient response to CBD for sleep and auto-immunity, Researching the right brand of CBD, What to look for
New Pathways Discovered for CBD’s Ability to Provide Pain and Anxiety Relief
While cannabidiol (CBD) is fast becoming a common compound for pain and anxiety relief, the exact pathways and dosage have remained elusive. A recent study, published in the journal PAIN, identified new pathways, beyond the endocannabinoid system, which explain its analgesic and anti-anxiety benefits. They are surprisingly different than what
Dr. Sanjay Gupta Spearheads American Pain Association’s Movement for Insurance Companies to Cover Cannabidiol (CBD) (CORRECTION)
BALA CYNWYD, Pa., Oct. 16, 2018 — Dr. Sanjay Gupta, President of the American Pain Association (APA)* and a pain management specialist based in Bala Cynwyd, Penn., is leading the push for insurance companies to cover cannabidiol (CBD) products for the treatment of pain and Opioid Use Disorder. Simply put,
Full-Spectrum Hemp for Inflammation and Sleep, Part 5 & Part 6
In these two videos, Derrick DeSilva, MD, discusses the value of full-spectrum hemp to address pain and inflammation. As he explains, full-spectrum hemp (FSH) has a novel dual mechanism of Cox-2 and Lox-5, similar to turmeric, to address pain. What you will learn: What are the mechanisms that addresses inflammation
Dr. Derrick DeSilva: Endocannabinoid System Clinical Uses, Dosage of Full-Spectrum Hemp Part 3 & 4
As part of our ongoing series on full-spectrum hemp, Dr. DeSilva and Today’s Practitioner’s Rob Lutz discusses the endocannabinoid system, hemp’s role as an adaptogen, what is the dosage for full-spectrum hemp?, along with many other pearls of wisdom. Click here for Part 1 & 2, Clinical Fundamentals of Full-Spectrum
